Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study-Reference-Cited by-同舟云学术

Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study

Published:2019-05-23 Issue:1 Volume:20 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Shibeshi Workineh,Sheth Anandi N.,Admasu Addisu,Berha Alemseged Beyene,Negash Zenebe,Yimer Getnet

Funder

NIH-Fogarty

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/s40360-019-0313-y.pdf

Reference45 articles.

1. Palomino JC, Martin A. Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics (Basel). 2014;3(3):317–40.

2. World Health Organization, Global Tuberculosis Report 2018, http://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1 . Accessed 10 Feb 2019.

3. Biadglegne F, Ulrich S, Rodloff AC. Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. Antimicrob Resist Infect Control. 2014;3:31.

4. Gilpin C, Korobitsyn A, Weyer K. Current tools available for the diagnosis of drug-resistant tuberculosis. Ther Adv Infect Dis. 2016;3(6):145–51.

5. WHO. Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update. Geneva: World Health Organization; 2016.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of the all-oral bedaquiline-containing regimen as treatment for pediatric multidrug/rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study;Expert Review of Anti-infective Therapy;2023-11-20

2. An Oxygen Supply Strategy for Sonodynamic Therapy in Tuberculous Granuloma Lesions Using a Catalase-Loaded Nanoplatform;International Journal of Nanomedicine;2023-11

3. Hearing assessment and treatment outcome in ENT tuberculosis at a tertiary hospital in India;The Egyptian Journal of Otolaryngology;2023-10-06

4. Adverse drug reactions and associated factors in multidrug-resistant tuberculosis: A retrospective review of patient medical records at Mbarara Regional Referral Hospital, Uganda;SAGE Open Medicine;2023-01

5. Antituberculous Agents for Pediatric Mycobacterial Diseases, and Hearing Loss;Hearing Loss in Congenital, Neonatal and Childhood Infections;2023